Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Aurinia Pharm Ord (AUPH)

Aurinia Pharm Ord (AUPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aurinia Pharm Ord 4464 MARKHAM STREET SUITE 1203 VICTORIA A1 V8Z 7X8 CAN

P: 250-744-2487 F: 604-369-4115

Description:

Aurinia Pharmaceuticals Inc. is a late stage biopharmaceutical company. It focuses on the development of therapeutic immunomodulating drug candidate. The company's lead drug includes Voclosporin for the treatment of lupus nephritis. Aurinia Pharmaceuticals Inc. is headquartered in Victoria, Canada.

Key Statistics

Overview:

Market Capitalization, $K 1,331,571
Enterprise Value, $K 865,491
Shares Outstanding, K 142,110
Annual Sales, $ 45,610 K
Annual Net Income, $ -180,970 K
Last Quarter Sales, $ 55,780 K
Last Quarter Net Income, $ -8,990 K
60-Month Beta 0.87
% of Insider Shareholders 3.70%
% of Institutional Shareholders 40.36%
Float, K 136,852
% Float 96.30%
Short Volume Ratio 0.49

Growth:

1-Year Return -42.95%
3-Year Return -48.80%
5-Year Return 85.91%
5-Year Revenue Growth 26,729.41%
5-Year Earnings Growth -102.90%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.06 on 11/03/22
Next Earnings Date 02/27/23
Earnings Per Share ttm -0.83
EPS Growth vs. Prev Qtr 76.00%
EPS Growth vs. Prev Year 84.62%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-50 on 11/08/13

AUPH Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -26.03%
Return-on-Assets % -22.85%
Profit Margin % -396.78
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 10.15
Price/Cash Flow N/A
Price/Book 3.09
Book Value/Share 2.98
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar